Cargando…
COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment
BACKGROUND: There is limited data on outcomes in cancer patients with coronavirus disease 2019 (COVID‐19) from lower middle‐income countries (LMICs). PATIENTS AND METHODS: This was an observational study, conducted between 12 April and 10 June 2020 at Tata Memorial centre, Mumbai, in cancer patients...
Autores principales: | Ramaswamy, Anant, Nayak, Lingaraj, Roy Moulik, Nirmalya, Sengar, Manju, Chinnaswamy, Girish, Jobanputra, Kunal, Shah, Minit J., Kapoor, Akhil, Joshi, Amit, Kumar, Amit, Gokarn, Anant, Bonda, Avinash, Cheriyalinkal Parambil, Badira, Prasad, Maya, Bagal, Bhausaheb, Dhamne, Chetan, Narula, Gaurav, Jain, Hasmukh, Ghosh, Jaya, Thorat, Jayashree, Bajpai, Jyoti, Menon, Nandini, Khattry, Navin, Bhargava, Prabhat, Punatar, Sachin, Gulia, Seema, Banavali, Shripad, Gupta, Sudeep, Srinivas, Sujay, Rath, Sushmita, Vora, Tushar, Noronha, Vanita, Patil, Vijay M., Ostwal, Vikas, Prabhash, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724305/ https://www.ncbi.nlm.nih.gov/pubmed/33128509 http://dx.doi.org/10.1002/cam4.3423 |
Ejemplares similares
-
Real-World Outcomes With Generic Pomalidomide in Relapsed Refractory Multiple Myeloma—Experience From a Tertiary Care Cancer Center
por: Bondili, Suresh Kumar, et al.
Publicado: (2021) -
COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the Infection
por: Parambil, Badira Cheriyalinkal, et al.
Publicado: (2021) -
Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia
por: Shetty, Dhanlaxmi, et al.
Publicado: (2021) -
Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
por: Shaikh, Anam Fatima, et al.
Publicado: (2020) -
NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies
por: Patkar, Nikhil, et al.
Publicado: (2020)